Clinicians often face uncertainty about whether they can rely on a negative chest x-ray (CXR) to rule out pneumonia in a child, even when other clinical signs and symptoms may have raised that concern ...

We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...

The ability of the Geneva homologous recombination deficiency (HRD) test to predict progression-free survival (PFS) in patients with high-grade ovarian cancer treated with poly (ADP-ribose) polymerase ...

RESTON, Va.--(BUSINESS WIRE)--Resonate, a leader in predictive consumer intelligence, today announced the launch of a groundbreaking suite of AI-powered solutions that will redefine how brands ...

Predictive Oncology Inc. has updated shareholders on its advancements in AI-driven drug discovery, specifically in biomarker discovery and drug repurposing, amid a growing biomarker discovery market ...

With the global biomarker discovery market valued at $14.5 billion in 2024 and projected to grow at a 19.4% CAGR through 2030, Predictive Oncology (POAI) is poised to lead in precision oncology ...